Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Gemcitabine (Agila)

Gemcitabine (Agila) is a medicine containing the active ingredient(s) gemcitabine. On this page you will find out more about Gemcitabine (Agila), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: gemcitabine

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Gemcitabine (Agila) 200 mg powder for injection, 5 vials

Consumer Medicine Information leaflet:

No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.

What this medicine is for

AS-Gemcitabine for Injection is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. AS-Gemcitabine for Injection is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. AS-Gemcitabine for Injection is also indicated for patients with 5-FU refractory pancreatic cancer. AS-Gemcitabine for Injection, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. AS-Gemcitabine for Injection, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. AS-Gemcitabine for Injection, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed >6 months following platinum-based therapy.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance White to off-white solid
Dosage Form Injection, powder for
Route of administration Intravenous
Medicine schedule
Pack of 1 vial: Prescription Only Medicine, or Prescription Animal Remedy
Pack of 10 vials: Prescription Only Medicine, or Prescription Animal Remedy
Pack of 5 vials: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store below 25 degrees Celsius
Storage conditions Protect from Light
Life time 2 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo